Related Experiment Video
Updated: Jan 1, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Pneumococcal Vaccines
D E Briles1, J C Paton2, R Mukerji1
1Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama.
Pneumococcal vaccines protect against Streptococcus pneumoniae infections. Alternative strategies, like protein-based vaccines, are needed due to serotype replacement limiting current vaccine effectiveness.
Area of Science:
- Microbiology
- Immunology
- Vaccinology
Background:
- Streptococcus pneumoniae (pneumococcus) is a major global cause of bacterial pneumonia, meningitis, and sepsis, particularly in children.
- Current polysaccharide conjugate vaccines effectively reduce invasive pneumococcal disease but face challenges from serotype replacement.
- The existence of over 98 pneumococcal serotypes makes expanding current vaccines costly and complex.
Purpose of the Study:
- To review past and present pneumococcal vaccines.
- To discuss current protein antigen vaccine candidates.
- To explore alternative strategies for combating pneumococcal disease.
Main Methods:
- Literature review of pneumococcal vaccines.
- Discussion of protein antigens as vaccine candidates.
- Exploration of alternative vaccine approaches.
Main Results:
- Polysaccharide conjugate vaccines have reduced disease but serotype replacement is an emerging issue.
- Protein antigens offer a potential serotype-independent vaccination strategy.
- Whole cell vaccines are also being considered as an alternative.
Conclusions:
- Serotype replacement necessitates the development of novel, broadly protective pneumococcal vaccines.
- Protein-based and whole cell vaccines represent promising avenues for future pneumococcal disease prevention.
- Continued research into serotype-independent strategies is crucial for global pneumococcal disease control.
Related Concept Videos
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia II: Pathophysiology
Pneumothorax-II
Clinical Manifestations:

